The Cell and Gene Meeting on the Mesa was held in La Holla, Calinfornia, USA, on October 5-7, 2016.
FIRM organized the Japan Workshop and Japan Lunch Meeting as well as had FIRM booth set up during the Meeting.
At the Japan Workshop, the presentations were made on perspectives on doing regenerative medicine business in Japan
and Japanese regulations in the field. Positive responses were received from the attendees.
The occasion helpd FIRM to further disseminate globally the information on Japanese regenerative medicine industry.
”Doing Business in Japan Workshop”
Chair: Kunihiko Suzuki, Vice Chairman, FIRM / Member, Board of Directors and Vice Chairman, MEDINET Co.
Welcome Remarks: Yuzo Toda, Chairman, FIRM / Senior Executive VP and Chief Technical Officer, Director,
Speaker: Hidetaka Nishimura, Director, Bio-Industry Division, Ministry of Economy, Trade & Industry (METI)
”New Era of Regenerative Medicine”
Speaker: Soichiro Isobe, Ph.D., Director, Medical Device Evaluation Division, Pharmaceutical Safety and
Environmental Health Bureau, Ministry of Health, Labour and Welfare (MHLW), Government of Japan
”Securing Quality, Safety and Efficacy for Regenerative Medical Products”
Speaker: Yoshiaki Maruyama, Ph.D., Review Director, Office of Cellular & Tissue-based Products,
Pharmaceuticals & Medical Devices Agency (PMDA)
“Consultation and Review Pathway for Regenerative Medical Products in Japan”
Closing Remarks: Akihiko Iwai, Ph.D., Vice Chairman, FIRM / Divisional SVP, Research Portfolio and Science,
Drug Discovery Research, Asteras Pharma Inc.
“Japan Lunch Meeting”
The respective companies had made their own presentations on their initiatives to regenerative medicine and/or support framework
for the industry. They are: Astellas Pharma Inc., CellSeed Inc., FUJIFILM Corporation, Healios K.K., Kawasaki Heavy Industries, Ltd.,
TAKARA BIO INC., Takeda Pharmaceutical Company Limited, and Terumo Corporation.